BR112013025794A2 - regimes de tratamento - Google Patents

regimes de tratamento

Info

Publication number
BR112013025794A2
BR112013025794A2 BR112013025794A BR112013025794A BR112013025794A2 BR 112013025794 A2 BR112013025794 A2 BR 112013025794A2 BR 112013025794 A BR112013025794 A BR 112013025794A BR 112013025794 A BR112013025794 A BR 112013025794A BR 112013025794 A2 BR112013025794 A2 BR 112013025794A2
Authority
BR
Brazil
Prior art keywords
treatment regimens
regimens
treatment
Prior art date
Application number
BR112013025794A
Other languages
English (en)
Inventor
G Sitchon Nicolas
Original Assignee
S1 Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S1 Biopharma Inc filed Critical S1 Biopharma Inc
Publication of BR112013025794A2 publication Critical patent/BR112013025794A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR112013025794A 2011-04-04 2012-04-03 regimes de tratamento BR112013025794A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161471505P 2011-04-04 2011-04-04
PCT/US2012/031991 WO2012138653A2 (en) 2011-04-04 2012-04-03 Treatment regimens

Publications (1)

Publication Number Publication Date
BR112013025794A2 true BR112013025794A2 (pt) 2018-05-29

Family

ID=46969773

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013025794A BR112013025794A2 (pt) 2011-04-04 2012-04-03 regimes de tratamento

Country Status (25)

Country Link
US (1) US20140038985A1 (pt)
EP (2) EP2694065B1 (pt)
JP (2) JP6279465B2 (pt)
KR (3) KR102141519B1 (pt)
CN (1) CN103635190B (pt)
AU (3) AU2012240388A1 (pt)
BR (1) BR112013025794A2 (pt)
CA (1) CA2832306A1 (pt)
CY (1) CY1120545T1 (pt)
DK (1) DK2694065T3 (pt)
EA (1) EA201391459A1 (pt)
ES (1) ES2662570T3 (pt)
HR (1) HRP20180417T1 (pt)
HU (1) HUE036977T2 (pt)
IL (1) IL228729A0 (pt)
LT (1) LT2694065T (pt)
MX (1) MX354989B (pt)
NO (1) NO2746714T3 (pt)
PL (1) PL2694065T3 (pt)
PT (1) PT2694065T (pt)
RS (1) RS57133B1 (pt)
SG (2) SG10201609297VA (pt)
SI (1) SI2694065T1 (pt)
WO (1) WO2012138653A2 (pt)
ZA (1) ZA201307760B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2694065T3 (pl) * 2011-04-04 2018-06-29 S1 Biopharma, Inc. Kompozycja do leczenia zaburzenia hipoaktywnego pożądania seksualnego
WO2014025814A1 (en) 2012-08-06 2014-02-13 S1 Pharmaceuticals, Inc. Treatment regimens
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005102342A1 (en) * 2004-04-22 2005-11-03 Boehringer Ingelheim International Gmbh New pharmaceutical compositions for the treatment of sexual disorders ii
US20060004076A1 (en) * 2004-06-30 2006-01-05 Inflabloc Pharmaceuticals, Inc. Co-administration of dehydroepiandrosterone (DHEA) congener with pharmaceutically active agents for treating inflammation
US7769770B2 (en) * 2004-07-14 2010-08-03 Microsoft Corporation Secondary index and indexed view maintenance for updates to complex types
JP4201747B2 (ja) * 2004-07-29 2008-12-24 三洋電機株式会社 自走式掃除機
JP2008538741A (ja) * 2005-03-04 2008-11-06 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 鬱病の治療用及び／又は予防用の医薬組成物
WO2008075162A2 (en) * 2006-12-15 2008-06-26 Pfizer Limited Selective mu opioid receptor antagonists for the treatment of female sexual dysfunction
PL2694065T3 (pl) * 2011-04-04 2018-06-29 S1 Biopharma, Inc. Kompozycja do leczenia zaburzenia hipoaktywnego pożądania seksualnego

Also Published As

Publication number Publication date
IL228729A0 (en) 2013-12-31
SI2694065T1 (en) 2018-06-29
JP6563998B2 (ja) 2019-08-21
KR20140031890A (ko) 2014-03-13
EA201391459A1 (ru) 2014-03-31
RS57133B1 (sr) 2018-07-31
DK2694065T3 (en) 2018-03-19
EP2694065B1 (en) 2017-12-13
EP3332780A1 (en) 2018-06-13
KR102033699B1 (ko) 2019-10-17
EP2694065A2 (en) 2014-02-12
JP2018030870A (ja) 2018-03-01
CA2832306A1 (en) 2012-10-11
JP2014510138A (ja) 2014-04-24
KR101893551B1 (ko) 2018-08-30
AU2012240388A8 (en) 2013-11-14
AU2017203815A1 (en) 2017-06-22
HUE036977T2 (hu) 2018-08-28
CN103635190A (zh) 2014-03-12
KR102141519B1 (ko) 2020-08-06
SG10201609297VA (en) 2016-12-29
MX354989B (es) 2018-03-28
PL2694065T3 (pl) 2018-06-29
AU2018264030A1 (en) 2018-12-06
ES2662570T3 (es) 2018-04-09
NO2746714T3 (pt) 2018-02-03
CY1120545T1 (el) 2019-07-10
WO2012138653A3 (en) 2012-12-06
LT2694065T (lt) 2018-04-10
SG194071A1 (en) 2013-11-29
PT2694065T (pt) 2018-03-20
EP2694065A4 (en) 2014-08-27
KR20180099910A (ko) 2018-09-05
JP6279465B2 (ja) 2018-02-14
HRP20180417T1 (hr) 2018-06-01
US20140038985A1 (en) 2014-02-06
CN103635190B (zh) 2016-09-07
WO2012138653A2 (en) 2012-10-11
KR20190120400A (ko) 2019-10-23
ZA201307760B (en) 2015-01-28
MX2013011623A (es) 2014-03-27
AU2012240388A1 (en) 2013-10-24

Similar Documents

Publication Publication Date Title
FR2977794B3 (fr) Outils de massage
BR112014007603A2 (pt) métodos de tratamento do câncer
HK1203378A1 (en) Enhanced treatment regimens using mtor inhibitors mtor
BR112013033974A2 (pt) terapia de combinação
DK2760886T3 (da) Immunocytokin-kombinationsterapi
FI20115876A0 (fi) Yhdistelmähoito
DK2489413T3 (da) Behandlingsapparat
SMT201600263B (it) Regimi terapeutici
BR112013022820A2 (pt) método de tratamento
IT1403577B1 (it) Dispositivo natante
IT1403578B1 (it) Dispositivo natante
BR112014000742A2 (pt) terapia de combinação de als
CO6880064A2 (es) Métodos terapéuticos
FI20115640A0 (fi) Yhdistelmähoito
FI20116093L (fi) Vettä käsittelevä laitos
CO6950447A2 (es) Aparato de tratamiento de espalda
CO6821930A2 (es) Métodos de tratamiento de biomasa
DE112012003429A5 (de) Mischereinrichtung
BR112013025794A2 (pt) regimes de tratamento
DE112012003438A5 (de) Mischereinrichtung
DK2694056T3 (da) Terapeutisk behandling
HK1214505A1 (zh) 治療方案
FI20115683A0 (fi) Pinnankäsittelylaite
BR112013017926A2 (pt) dispositivo de construção
UA22961S (uk) Масажер

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements